Verification of drug license & valid prescription is strongly advised for the users before dealing in medicines

120 Mg Montijan FX Fexofenadine Montelukast Tablet

₹ 200/Box

Strength120 mg
Packaging Size100 Tablets
Packaging TypeBox
BrandMontijan FX
CompositionFexofenadine Montelukast
TreatmentThis medicine is used to treat allergy symptoms like runny nose, sneeze and cough
AvailabilityIn Stock
View in Hindi 120 मिग्रा मोंटिजन एफएक्स फेक्सोफेनाडिन मोनटेलुकास्ट टैबलेट
Treatment of allergy symptoms such as runny nose, stuffy nose, sneezing, watery eyes, and congestion or stuffiness...

Exports To: Bangladesh | United States Of America | Nepal | Australia | United Kingdom

Shipping Information

PriceExcluding all taxes
ShippingAs per delivery location

Product Image

120 Mg Montijan FX  Fexofenadine Montelukast Tablet-1120 Mg Montijan FX  Fexofenadine Montelukast Tablet-2

About the Company

GST Registration Date
Jul 2019
Legal Status of Firm
Limited Company
Nature of Business
Trader - Wholesaler/Distributor
Number of Employees
Upto 10 People
Annual Turnover
25 - 100 Cr
IndiaMART Member Since
July 2014
GST
04**********1ZR
Import Export Code (IEC)
*******72E
Exports to
Bangladesh | United States Of America | Nepal | Australia | United Kingdom

Established in the year of 2019, We “Janus Biotech India Private Limited” are Wholesaler,Distributor And Exporter of an Pharmaceutical Tablets, Pharmaceutical Tablets And Capsule, PCD Pharma Franchise, Pharmaceutical Syrup, Medicine Products, Pharmaceutical Capsules, Ayurvedic Syrup and Tablets and Capsules, Pharmaceutical Injection. We direct all our activities to cater the expectations of customers by providing them excellent quality products as per their gratification. Moreover, we follow moral business policies and crystal pure transparency in all our transactions to keep healthy relations with the customers.

For our accomplishment story, we are grateful to our Mr. Harsimran Singh, whose continual backing and direction have been useful to us for attaining exponential development in the current market.